February 27, 2017 Social Clips by Wendy Henderson MS Researchers Look at Medical Marijuana for Neuropathic Pain A Canadian research group is looking at the use of cannabis oil as a treatment for neuropathic pain in multiple sclerosis patients. Medical marijuana now available in controlled-dose capsules in New York. Read more here. …
February 23, 2017 News by Patricia Silva, PhD Brazil Allows HempMeds to Import RSHO Cannabidiol for MS Treatment The Brazilian government has authorized HempMeds Brasil, a unit of California-based Medical Marijuana, to import the parent company’s hemp cannabidiol (CBD) oil flagship product — known as Real Scientific Hemp Oil (RSHO) — for the management of multiple sclerosis…
February 20, 2017 Columns by admin MS Patient’s Pick of the Week’s News: BFitLifestyles, Cannabis, ARNet, Bioness and More Here`s my Pick of the Week’s News as published by Multiple Sclerosis News Today. Fitness Trainer and MS Patient, Dolly Stokes, Launches BFitLifestyles Website with Husband Looking after what you eat and exercising according to your…
February 16, 2017 News by Joana Fernandes, PhD Researchers Test Medical Cannabis as Treatment for MS-Linked Neuropathic Pain Canadian researchers are testing mice to see if cannabinoid oil products — a common medical marijuana treatment — could help alleviate the neuropathic pain that often afflicts patients with multiple sclerosis (MS). The preclinical study, “Identifying the molecular mechanisms involved…
February 7, 2017 News by Patricia Silva, PhD 95% of MS Patients Open to Marijuana Treatment, 73% Have Tried It Ninety-five percent of multiple sclerosis (MS) patients believe medical marijuana should be a treatment option, according to a GeneFo online survey. The survey also showed that almost 73 percent had tried it, even though about half said they hadn’t received information…
January 18, 2017 News by Patricia Silva, PhD Majority of Irish Physicians Approve of Cannabis as MS Treatment, Survey Finds Most Irish general practitioners (GPs) are against decriminalizing cannabis use, but many, especially those over age 50, say it can be useful for treating multiple sclerosis (MS) and other medical conditions, according to a recent survey. The results are detailed in…
January 17, 2017 News by Patricia Silva, PhD Cannabis Compounds Ease Spasticity in MS, National Academies’ Report States Certain cannabinoids reduce spasticity symptoms in multiple sclerosis (MS) patients, according to a report from The National Academies of Sciences, Engineering, and Medicine that scrutinized published research about the benefits and hazards of cannabis and cannabinoid use. Cannabinoids also show proven effect in other areas that…
November 17, 2016 News by Charles Moore BAS Joins with Montel Williams in Effort to Bring Cannabis Products for MS to Market BAS Research, recently granted California’s first medicinal marijuana manufacturing and research license, is teaming with Montel Williams’ LenitivLabs startup to begin developing, producing and marketing medical-grade cannabis products. BAS’ goal is to replace the social stigma associated with cannabis by…
November 16, 2016 News by Joana Fernandes, PhD Growing Approval of Cannabis Use in US Expands a Major Market, But Tensions Evident Voters in four U.S. states on Nov. 8 chose to legalize the recreational use of marijuana, and those in three other states approved the medicinal use of cannabis — all gains for pharmaceutical and other companies designing cannabis-based therapies for people…
November 7, 2016 News by Patricia Silva, PhD Testing Stages of Marijuana Gum to Treat Spasticity in MS Can Be Followed Online Medical Marijuana announced that Axim Biotechnologies, a cannabinoid-based product developer in which it owns a strategic interest, has released a product pipeline chart highlighting development timelines for its cannabinoid-based therapeutics, including those for multiple sclerosis (MS) patients. The chart illustrates the…
